Paid Clinical Trials in Canton, OH
As of July 2026, 146 paid clinical trials are recruiting in Canton, Ohio. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Canton offers studies at sites including Aultman Health Foundation for conditions such as Breast Cancer, Multiple Myeloma, Ovarian Cancer, Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Canton
Trials by drug in Canton
Filter results
Newly added in Canton
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
139 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
GEMINI-NSCLC: NSCLC Biomarker Study
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
Top Research Study Locations in Canton
Researchers run research studies in Canton, OH at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Aultman Health Foundation | Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | 31 |
| Gabrail Cancer Center | Colorectal Neoplasms, Hematologic Malignancies, Myelofibrosis | 19 |
| Gabrail Cancer Center Research | Myelodysplastic Syndromes, Acute Myeloid Leukemia, Advanced Cancer | 15 |
| Aultman Hospital | Acute Lower Limb Arterial Occlusion, Anal Cancer, Atrial Fibrillation | 9 |
| Cleveland Clinic Mercy Hospital | Stage IVA Prostate Cancer AJCC v8, Acute Myelogenous Leukemia, Breast Cancer | 9 |
| GSK Investigational Site | Gastrointestinal Stromal Neoplasms, Lymphoma, Non-Hodgkin, Multiple Myeloma | 6 |
| Gabrail Cancer & Research Center | ALK-Positive Large B-Cell Lymphoma, Acneiform Eruption Due to Chemical, Breast Cancer | 5 |
| Gabrail Cancer Research Center | Solid Tumor, Advanced Cancer, Breast Cancer | 3 |
| Apex Clinical Research Center - Canton | Plaque Psoriasis | 2 |
| Apex Clinical Research Center, LLC | Hidradenitis Suppurativa (HS), Plaque Psoriasis | 2 |
| Diabetes and Endocrinology Associates of Stark County | Type 2 Diabetes | 2 |
| Gabrail Cancer and Research Center | Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations | 2 |
| Neuro-Behavioral Clinical Research | Bipolar I Disorder, Schizophrenia | 2 |
| NeuroScience Research Center | Focal Epilepsy | 2 |
| NeuroScience Research Center, LLC | OSA, Parkinson Disease | 2 |
| Gastroenterology & Hepatology Specialists, Inc. | Ulcerative Colitis, Crohn's Disease | 2 |
| Alkermes Investigational Site | Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2 | 1 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Aultman | Epidermal Growth Factor Receptor Gene Mutation, Non Small Cell Lung Cancer, Stage III Lung Cancer | 1 |
| Aultman Cardiology Clinical Trials | Cardiovascular Disease | 1 |
| Aultman Hospital, Cardiovascular Consultants, Inc | Atherosclerotic Cardiovascular Disease, Obesity, Overweight | 1 |
| Aultman Medical Group | Cancer | 1 |
| Aultman Timken Family Cancer Center | Breast Cancer | 1 |
| Cleveland Clinic - Mercy Hospital | Triple-Negative Breast Cancer | 1 |
| Cleveland Clinic Mercy Hospital Cancer Center | Extensive-stage Small-cell Lung Cancer | 1 |
Active & Upcoming Studies in Canton (2026)
Recruiting trials in Canton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (83 active studies)
- A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL · Phase 1, Phase 2 · GlaxoSmithKline
- A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma · Phase 3 · Janssen Research & Development, LLC
Cardiovascular (6 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Diabetes & metabolic (5 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy · Phase 2 · Biomea Fusion Inc.
Neurology & pain (4 active studies)
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease · Phase 4 · Impax Laboratories, LLC
- Long-term Safety and Tolerability of BHV-7000 · Phase 2 · Biohaven Therapeutics Ltd.
Mental health & behavior (2 active studies)
- 52-week Open Label Safety-Tolerability Study · Phase 3 · LB Pharmaceuticals Inc.
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. · Phase 2 · LB Pharmaceuticals Inc.
Pediatric (1 active study)
- Study of SGR-1505 in Mature B-Cell Neoplasms · Phase 1 · Schrödinger, Inc.
Common conditions studied in Canton
- Breast Cancer (7 active studies)
- Multiple Myeloma (5 active studies)
- Ovarian Cancer (4 active studies)
- Small Cell Lung Cancer (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
Leading research sponsors in Canton
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- NRG Oncology
- AstraZeneca
- GlaxoSmithKline
Frequently asked questions
How many paid clinical trials are currently recruiting in Canton?
There are approximately 146 recruiting clinical trials in Canton, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Canton pay participants?
Most recruiting trials in Canton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Canton?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Canton?
The most common conditions under active study in Canton include Breast Cancer (7), Multiple Myeloma (5), Ovarian Cancer (4), Small Cell Lung Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Canton?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Canton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Canton?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Canton?
Recruiting research sites in Canton include Aultman Health Foundation, Gabrail Cancer Center, Gabrail Cancer Center Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Canton right now?
The largest active categories in Canton are Cancer & tumors (83), Cardiovascular (6), Diabetes & metabolic (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.